ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,520.69
0.38%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Corbus Pharmaceuticals Holdings Inc (CRBP)

  7. Corbus Pharmaceuticals Holdings Inc (CRBP) Noticias

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CRBP
FechaHoraFuenteTítuloSímboloCompañía
03/12/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202418:48Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/11/202415:58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/10/202417:06Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
20/08/202415:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
20/08/202415:45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202416:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/05/202415:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202415:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202415:41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202416:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202408:16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202406:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202305:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/06/202315:59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/06/202315:54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/06/202305:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
22/05/202315:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
19/05/202308:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/05/202316:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202315:32Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/04/202315:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
10/03/202315:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202315:30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/03/202309:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
15/02/202305:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/11/202216:51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/11/202205:25TipRanksCorbus Pharmaceuticals (CRBP) Gets a Buy from H.C. WainwrightNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/10/202207:05PR Newswire (US)Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual MeetingNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
12/10/202216:09Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP

Su Consulta Reciente

BIT
NFLX
Netflix
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados